Skip to main content

Table 2 Demographic and clinical characteristics of the patients all patients

From: ECOG-ACRIN 2399: analysis of patient related outcomes after Chemoradiation for locally advanced head and neck Cancer

Characteristic Total
(N = 105)
N (%)
Alive
(N = 78)
N (%)
Deceased
(N = 27)
N (%)
p-value
Male 86 (81.9) 63 (80.8) 23 (85.2) 0.601
White 88 (83.8) 66 (84.6) 22 (81.5) 0.706
Primary Site     0.052
 Larynx 38 (36.2) 24 (30.8) 14 (51.9)  
 Pharynx 67 (63.8) 54 (69.2) 13 (48.1)  
T-Stage     0.630
 I-II 43 (41.0) 33 (42.3) 10 (37.0)  
 III-IV 62 (59.0) 45 (57.7) 17 (63.0)  
N-Stage     0.035
 0–1 45 (42.9) 38 (48.7) 7 (25.9)  
 2–3 60 (57.1) 40 (51.3) 20 (74.1)  
Surgery dissection (primary site) 14 (13.3) 7 (9.0) 7 (25.9) 0.035
Cell differentiationa     0.486
 Poorly 35 (38.5) 26 (39.4) 9 (36.0)  
 Moderately 48 (52.7) 33 (50.0) 15 (60.0)  
 Well 8 (8.8) 7 (10.6) 1 (4.0)  
Best overall responseb     < 0.001
 Progressive disease 4 (4.3) 1 (1.4) 3 (13.6)  
 Stable disease 22 (23.4) 12 (16.7) 10 (45.5)  
 Partial response 32 (34.0) 25 (34.7) 7 (31.8)  
 Complete response 36 (38.3) 34 (47.2) 2 (9.1)  
Weight lossc
(previous 6 months)
    0.036
  > 10% body weight 12 (12.2) 5 (6.9) 7 (26.9)  
 5–10% body weight 18 (18.4) 15 (20.8) 3 (11.5)  
  < 5% body weight 68 (69.4) 52 (72.2) 16 (61.5)  
  Mean (SD) Mean (SD) Mean (SD)  
Age 58.9 (10.7) 57.5 (9.8) 62.6 (12.4) 0.034
  1. a N = 91; b N = 94; c N = 98